These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 20658994)

  • 41. In-Cell NMR Study of Tau and MARK2 Phosphorylated Tau.
    Zhang S; Wang C; Lu J; Ma X; Liu Z; Li D; Liu Z; Liu C
    Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30587819
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization of Neuronal Tau Protein as a Target of Extracellular Signal-regulated Kinase.
    Qi H; Prabakaran S; Cantrelle FX; Chambraud B; Gunawardena J; Lippens G; Landrieu I
    J Biol Chem; 2016 Apr; 291(14):7742-53. PubMed ID: 26858248
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Proline Conformation in a Functional Tau Fragment.
    Ahuja P; Cantrelle FX; Huvent I; Hanoulle X; Lopez J; Smet C; Wieruszeski JM; Landrieu I; Lippens G
    J Mol Biol; 2016 Jan; 428(1):79-91. PubMed ID: 26655856
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nuclear Magnetic Resonance Spectroscopy for the Identification of Multiple Phosphorylations of Intrinsically Disordered Proteins.
    Danis C; Despres C; Bessa LM; Malki I; Merzougui H; Huvent I; Qi H; Lippens G; Cantrelle FX; Schneider R; Hanoulle X; Smet-Nocca C; Landrieu I
    J Vis Exp; 2016 Dec; (118):. PubMed ID: 28060278
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Studying the natively unfolded neuronal Tau protein by solution NMR spectroscopy.
    Lippens G; Sillen A; Smet C; Wieruszeski JM; Leroy A; Buée L; Landrieu I
    Protein Pept Lett; 2006; 13(3):235-46. PubMed ID: 16515451
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Alzheimer's disease related tau protein as a new target for chemical protein engineering.
    Broncel M; Krause E; Schwarzer D; Hackenberger CP
    Chemistry; 2012 Feb; 18(9):2488-92. PubMed ID: 22231520
    [No Abstract]   [Full Text] [Related]  

  • 47. Nuclear magnetic resonance analysis of the acetylation pattern of the neuronal Tau protein.
    Kamah A; Huvent I; Cantrelle FX; Qi H; Lippens G; Landrieu I; Smet-Nocca C
    Biochemistry; 2014 May; 53(18):3020-32. PubMed ID: 24708343
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of the Tau phosphorylation pattern that drives its aggregation.
    Despres C; Byrne C; Qi H; Cantrelle FX; Huvent I; Chambraud B; Baulieu EE; Jacquot Y; Landrieu I; Lippens G; Smet-Nocca C
    Proc Natl Acad Sci U S A; 2017 Aug; 114(34):9080-9085. PubMed ID: 28784767
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of tau kinases in Alzheimer's disease.
    Dolan PJ; Johnson GV
    Curr Opin Drug Discov Devel; 2010 Sep; 13(5):595-603. PubMed ID: 20812151
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Direct Observation of Aggregation-Induced Backbone Conformational Changes in Tau Peptides.
    Jiji AC; Shine A; Vijayan V
    Angew Chem Int Ed Engl; 2016 Sep; 55(38):11562-6. PubMed ID: 27513615
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Substituted 2-aminothiazoles are exceptional inhibitors of neuronal degeneration in tau-driven models of Alzheimer's disease.
    Lagoja I; Pannecouque C; Griffioen G; Wera S; Rojasdelaparra VM; Van Aerschot A
    Eur J Pharm Sci; 2011 Aug; 43(5):386-92. PubMed ID: 21664968
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tau aggregation in Alzheimer's disease: what role for phosphorylation?
    Lippens G; Sillen A; Landrieu I; Amniai L; Sibille N; Barbier P; Leroy A; Hanoulle X; Wieruszeski JM
    Prion; 2007; 1(1):21-5. PubMed ID: 19164903
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phosphorylated full-length Tau interacts with 14-3-3 proteins via two short phosphorylated sequences, each occupying a binding groove of 14-3-3 dimer.
    Neves JF; Petrvalská O; Bosica F; Cantrelle FX; Merzougui H; O'Mahony G; Hanoulle X; Obšil T; Landrieu I
    FEBS J; 2021 Mar; 288(6):1918-1934. PubMed ID: 32979285
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Loss of intramolecular electrostatic interactions and limited conformational ensemble may promote self-association of cis-tau peptide.
    Barman A; Hamelberg D
    Proteins; 2015 Mar; 83(3):436-44. PubMed ID: 25524218
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Remodeling of the conformational ensemble of the repeat domain of tau by an aggregation enhancer.
    Akoury E; Mukrasch MD; Biernat J; Tepper K; Ozenne V; Mandelkow E; Blackledge M; Zweckstetter M
    Protein Sci; 2016 May; 25(5):1010-20. PubMed ID: 26940799
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The dynamic structure of filamentous tau.
    Bibow S; Mukrasch MD; Chinnathambi S; Biernat J; Griesinger C; Mandelkow E; Zweckstetter M
    Angew Chem Int Ed Engl; 2011 Nov; 50(48):11520-4. PubMed ID: 21990182
    [No Abstract]   [Full Text] [Related]  

  • 57. 14-3-3/Tau Interaction and Tau Amyloidogenesis.
    Chen Y; Chen X; Yao Z; Shi Y; Xiong J; Zhou J; Su Z; Huang Y
    J Mol Neurosci; 2019 Aug; 68(4):620-630. PubMed ID: 31062171
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hiding in plain sight: Complex interaction patterns between Tau and 14-3-3ζ protein variants.
    Crha R; Kozeleková A; Hofrová A; Iľkovičová L; Gašparik N; Kadeřávek P; Hritz J
    Int J Biol Macromol; 2024 May; 266(Pt 2):130802. PubMed ID: 38492709
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Animal models reveal role for tau phosphorylation in human disease.
    Götz J; Gladbach A; Pennanen L; van Eersel J; Schild A; David D; Ittner LM
    Biochim Biophys Acta; 2010 Oct; 1802(10):860-71. PubMed ID: 19751831
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tau and src family tyrosine kinases.
    Lee G
    Biochim Biophys Acta; 2005 Jan; 1739(2-3):323-30. PubMed ID: 15615649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.